Miller et al. [32] investigated TAS/TAC concentration, as well as superoxide dismutase (SOD) and catalase (CAT) activity in MS patients participating in kinesitherapy and a series of 10 WBC sessions, MS patients participating only in kinesitherapy sessions, and a control group of healthy subjects. This evidence concerns the gene SOD1 and myeloid sarcoma.